AI Article Synopsis
- Prostacyclin therapy is essential for treating pulmonary arterial hypertension (PAH).
- Inhaled prostacyclins are effective and safer than other methods since they minimize side effects throughout the body.
- This text discusses a unique case where the use of inhaled prostacyclin led to serious complications, including bronchospasm and acute respiratory failure.
Article Abstract
Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life-threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157496 | PMC |
| http://dx.doi.org/10.1002/pul2.12396 | DOI Listing |
Publication Analysis
Top Keywords
bronchospasm acute
8
acute respiratory
8
respiratory failure
8
failure associated
8
associated inhaled
8
inhaled prostacyclin
8
prostacyclin therapy
8
severe bronchospasm
4
therapy prostacyclin
4
therapy mainstay
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!